password

username

• Newsletters
• Senders
• Contribute
• Faq

Newsletter preview

Date:

Thu, October 26, 2006 09:35:35 AM

From:

Outsourcing-Pharma

Subject:

26/10 PPD/Outsourcing services/SAFC/Pharma R&D/Intertek

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com   >  PPD Q3 profit increases, boosting dividend in the process   >  A world of outsourcing awaits Part IV other contract services   >  Curalogic appoints SAFC to provide protein research services   >  Big Pharma splash out on R&D   >  Intertek ASG expands biopharmaceuticals characterisation service

Other top industry news   >  Lilly injects $560m into US biotech plant expansion but will shut UK plant   >  Dry-powder inhaler 'revolution' unveiled   >  Big pharma business model needs to change   >  DSM accelerates anti-infective activity

	Outsourcing Pharma
Search Forward to a colleague		Thursday 26 October 2006

	Sponsored by Cardinal Health Cardinal Health enhances drug delivery Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here Access full stories PPD Q3 profit increases, boosting dividend in the process PPD managed a net revenue of $313.1m (€250m) for the third quarter of 2006, buoyed on by the strong performance by the company's developmental segment... Read A world of outsourcing awaits Part IV other contract services Pharmaceutical companies are beginning to catch up with other industry sectors that take an increasingly realistic view of what they consider a core competency and outsourcing what is left Outsourcing-Pharma... Read Curalogic appoints SAFC to provide protein research services Curalogic, a Danish biotechnology company, has appointed SAFC's Pharma business segment to provide protein isolation, extraction and purification services... Read Big Pharma splash out on R&D Developing new drugs represents an enormous expense for pharma companies with top firms spending up to £4bn (€6bn) a year on R&D, according to new industry report... Read Intertek ASG expands biopharmaceuticals characterisation service British-based analysis services provider Intertek ASG has announced it is expanding its analytical services to meet the growing demand for macromolecule characterisation... Read
	All News Headlines for: October | September | August
	Sponsored by SF-Chem High-quality intermediates SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here

Previous Headlines > Clinphone heads down under ... > Charles River Labs awarded $11 ... > A world of outsourcing awaits ... > A world of outsourcing awaits ... > FDA to review electronic signa ... > MDS Pharma opens first US cent ... > A world of outsourcing awaits ... > Contamination risks challenge ... > Overcoming intellectual proper ... > US and EU pharma trade bodies ... Product Categories > Product & Supplier News - Contract Manufacturing Related Web Sites > In-PharmaTechnologist.com > DrugResearcher.com > BioPharmaReporter.com > All our Websites

Other top industry news Lilly injects $560m into US biotech plant expansion but will shut UK plant Drug maker Eli Lilly has completed the first phase of a $560m (€446m) expansion of its biotech facility in Indianapolis, US, in order to match the growing number of biological drugs in its pipeline... Read Dry-powder inhaler 'revolution' unveiled A new dry powder inhaler that may cost less than a syringe and deliver 40 per cent more active drug than current inhalers has been unveiled by its maker, Cambridge Consultants... Read Big pharma business model needs to change The current big pharma business model is not sustainable for the future and will need to change, delegates heard at the recent Financial Times (FT) global Pharmaceuticals and Biotechnology Conference... Read DSM accelerates anti-infective activity Using a processing technique described as "revolutionary," DSM is accelerating up its activity in the anti-infective arena and targeting new active pharmaceutical ingredients (APIs) that it can develop into cost-competitive... Read Events - Publisher's Choice STAY up-to-date with pharmaceutical Innovations Visit our regularly updated events calendar and learn about important events within the industry today ... Read ELNS & Laboratory Informatics 4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read Sponsored by Cardinal Health Comprehensive Pulmonary & Nasal Dosage Forms Cardinal Health offers comprehensive pulmonary and nasal development services to take your product from concept and feasibility studies through regulatory approval and commercial-scale manufacturing. Click Here Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals Breaking news Pharmaceutical Technology Drug Discovery Outsourcing Pharma Biopharmaceutical Science and Business Laboratory Equipment Access Decision News Media e-newsletters for the food, beverage & nutition industries click here

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences | Change your email address | ***
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

 

© 2007 - The Code Kitchen for interface design and text. Newsletter content remains the copyright of the respective publishers.
Contact: info@newsletterarchive.org